These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34824144)

  • 1. LGI1 antibody encephalitis: acute treatment comparisons and outcome.
    Rodriguez A; Klein CJ; Sechi E; Alden E; Basso MR; Pudumjee S; Pittock SJ; McKeon A; Britton JW; Lopez-Chiriboga AS; Zekeridou A; Zalewski NL; Boeve BF; Day GS; Gadoth A; Burkholder D; Toledano M; Dubey D; Flanagan EP
    J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):309-315. PubMed ID: 34824144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
    Li Y; Song F; Liu W; Wang Y
    Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
    Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI.
    Jia Y; Wang H; Zhang M; Wei M; Huang Z; Ye J; Liu A; Wang Y
    Acta Neurol Belg; 2023 Jun; 123(3):849-856. PubMed ID: 35527332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
    Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
    Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
    Li Z; Cui T; Shi W; Wang Q
    Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rituximab on seizure control and cognitive symptoms in leucine-rich, glioma-inactivated 1 (LGI1) limbic encephalitis: a high-density electroencephalography case study.
    Cheli M; Dinoto A; Tommasini V; Ajčević M; Stella G; Catalan M; Stokelj D; Sartori A; Manganotti P
    Epileptic Disord; 2020 Oct; 22(5):678-682. PubMed ID: 33146142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
    Li J; Li H; Wang Y; Zhao X; Wang S; Li L
    Front Immunol; 2022; 13():1071219. PubMed ID: 36685530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
    Michael S; Waters P; Irani SR
    Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
    Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
    Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
    Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
    Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.
    Lee WJ; Lee ST; Byun JI; Sunwoo JS; Kim TJ; Lim JA; Moon J; Lee HS; Shin YW; Lee KJ; Kim S; Jung KH; Jung KY; Chu K; Lee SK
    Neurology; 2016 May; 86(18):1683-91. PubMed ID: 27037228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.
    van Sonderen A; Thijs RD; Coenders EC; Jiskoot LC; Sanchez E; de Bruijn MA; van Coevorden-Hameete MH; Wirtz PW; Schreurs MW; Sillevis Smitt PA; Titulaer MJ
    Neurology; 2016 Oct; 87(14):1449-1456. PubMed ID: 27590293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
    Malter MP; Frisch C; Schoene-Bake JC; Helmstaedter C; Wandinger KP; Stoecker W; Urbach H; Surges R; Elger CE; Vincent AV; Bien CG
    J Neurol; 2014 Sep; 261(9):1695-705. PubMed ID: 24935858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
    Zhang WJ; Gao N
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7556-7560. PubMed ID: 36314326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy.
    Dubey D; Britton J; McKeon A; Gadoth A; Zekeridou A; Lopez Chiriboga SA; Devine M; Cerhan JH; Dunlay K; Sagen J; Ramberger M; Waters P; Irani SR; Pittock SJ
    Ann Neurol; 2020 Feb; 87(2):313-323. PubMed ID: 31782181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.